deCODEme disappoints, predicting diabetes, and more
Some recent posts from VentureBeat Life Sciences that might be worth your time:
1) Two pieces (here and here) on the latest “personal genomics” service, deCODEme. VentureBeat finds it underpowered and badly implemented;
2) Pieces on cutting-edge diagnostic tests that aim to predict whether you’ll get diabetes or develop Alzheimer’s disease;
3) A look at iMedix, a Health 2.0 site that won a Crunchie award. It tries to mix health-search with social community, but VentureBeat LifeSciences says it… Continue Reading
deCODEme’s underwhelming personal-genomics service
(UPDATED: See below.)
Personal-genomics vendors like 23andMe and deCODEme, which promise to give ordinary individuals a peek at their genetic inheritance, have received a ton of press attention since they launched last November (not least of all from us — see here and here for starters). Unless you happened to have a spare $1,000 laying around, however, you were pretty much out of luck if you simply wanted to know exactly what you might be getting for… Continue Reading